Bausch Health, Canada Inc. recalls all lots of Emerade epinephrine auto-injectors (0.3 mg and 0.5 mg strengths) due to possible device failure
Consumer Products
May 5th, 2023 @ 12:00 PM

Basic Details

Alert type: Consumer product recall
Category: Health product
Issue: Health products - Other
Product: Emerade epinephrine auto-injectors, 0.3 mg (DIN 02458446) and 0.5 mg (DIN 02458454)
What to do: Return your Emerade auto-injector to your pharmacy for a suitable replacement as soon as possible. Make sure you know how to use the replacement. Do not return or dispose of your Emerade auto-injector until a replacement is obtained. If a life-threatening allergic reaction (anaphylaxis) happens before you can get a replacement, use your recalled Emerade and then seek emergency medical attention.

Images
Click to enlarge

Emerade Pen 0.3mgEmerade Pen 0.5mg

Products

Expiration DateDINProductLot Number
2023-08-3002458454Emerade 0.5 mgZ0088C3A
2024-08-3102458454Emerade 0.5 mgZ0153C2A
2023-06-3002458454Emerade 0.5 mgZ0034C1A
2023-08-3002458454Emerade 0.5 mgZ0076C2A
2024-10-3102458446Emerade 0.3 mgZ0198B3B
2023-05-3102458454Emerade 0.5 mgY0225C1A
2023-06-3002458446Emerade 0.3 mgZ0034B2C
2023-08-3102458454Emerade 0.5 mgZ0088C3B
2024-10-3102458446Emerade 0.3 mgZ0198B3A
2024-05-3102458454Emerade 0.5 mgZ0128C1B
2023-05-3102458446Emerade 0.3 mgY0225B2A
2024-08-3102458454Emerade 0.5 mgZ0153C2B
2023-08-3002458446Emerade 0.3 mgZ0076B1A
2024-11-3002458454Emerade 0.5 mgZ0236C1C

Recall Monitor

Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.

You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.

Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.

Recall Monitor is not endorsed by, or is an official product of the Government of Canada.

Made with in Vancouver, BC

© Mad Filaments Software Inc.